Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hodgkin Disease × deltacortene × Clear all

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Plasmablastic Lymphoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 12 Etoposide 10 Brentuximab Vedotin 9 Doxorubicin 8 fludarabine phosphate 7 Vincristine 6 Vinblastine 6 Mycophenolic Acid 6 Melphalan 6 Dacarbazine 6 Bleomycin 6 Cyclosporine 5 camrelizumab 4 Rituximab 4 Radiotherapy 4 Peripheral Blood Stem Cell Transplantation 4 Nivolumab 4 Gemcitabine 4 Filgrastim 4 Decitabine 4 Cytarabine 4 Busulfan 4 Bendamustine Hydrochloride 4 pembrolizumab 3 Tacrolimus 3 Prednisone 3 Ifosfamide 3 Antilymphocyte Serum 3 fludarabine 2 Whole-Body Irradiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00795613 2015-10-19

HD0607

Ospedale Santa Croce-Carle Cuneo

Phase 2 Unknown

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡